Panelists include top executives from Johnson & Johnson, Medtronic, and Bristol-Myers Squibb
DURHAM, N.C.--(BUSINESS WIRE)-- CED, the southeast’s largest entrepreneurial support organization, today announced that Christopher Viehbacher, CEO of Sanofi, will be the opening keynote speaker for the 21st annual CED Life Science Conference, to be held Feb 15-16, 2012, at the Raleigh Convention Center.
The conference chairs are Victor J. Dzau, MD, chancellor for health affairs at Duke University and president and CEO of Duke University Health System, and Robert A. Ingram, general partner, Hatteras Venture Partners.
Other speakers confirmed for the conference include Alex Gorsky, vice chairman, Johnson & Johnson; Bill Hawkins, retired chairman and CEO, Medtronic, Inc.; Kris H. Jenner, vice president, T. Rowe Price Group; and Jeremy Levin, senior vice president, strategy, alliances and transactions, Bristol-Myers Squib.
“This conference represents the largest gathering in the southeast of the region’s life science community,” said Joan Siefert Rose, CED president. “We are excited to present a top-tier line-up of speakers for this event, which showcases a robust industry for North Carolina.”
The CED Life Science Conference is presented in partnership with the North Carolina Biotechnology Center and North Carolina Biosciences. Early registration and a full conference agenda are online at http://www.cednc.org/lifescience.
CED’s mission is to identify, enable and promote emerging growth companies and to accelerate the entrepreneurial culture of the Research Triangle and North Carolina.
About NC Biotechnology Center
The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.
NCBIO is dedicated to promoting the future growth and development of North Carolina’s bioscience industry. NCBIO advocates for state and federal public policies that encourage the growth of life science companies, support the development of a strong life science workforce, and promote research and technology transfer at universities and other institutions. The Organization also provides members opportunities to network, collaborate and save money. NCBIO’s ultimate goal is to help North Carolina’s bioscience community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life for citizens of North Carolina and people around the world.
Jason H Parker, 919-266-0466
Associate Director, Marketing & Communications
KEYWORDS: United States North America North Carolina
INDUSTRY KEYWORDS: Health Biotechnology Research Science